drugset
drugset / Trial / NCT05549401

Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348

NCT05549401 ↗

Phase 1 Completed 32 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A phase I clinical trial to evaluate the tolerability and the pharmacokinetics of CKD-348.

Timeline

Start
2022-09-29
Primary completion
2022-11-30
Completion
2022-12-09

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-348(4) F1 Unknown 1 unknown Oral
Subject CKD-348(4) F2 Unknown 1 unknown Oral
Subject CKD-828 Unknown — Oral
Subject D097 Unknown — Oral
Subject D337 Unknown — Oral

Indications

No indication recorded.